CIK 0001395937 · Large accelerated filer
Syndax Pharmaceuticals Inc
Sign in to watch- Ticker
- SNDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320162505
- Phone
- 781-419-1400
- Business address
- 730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $113,716
- in 1 filing, $114K under 10b5-1 plans
Net −$113,716. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-01 | Morrison Briggs President, Head of R&D | Sale | −70,545 | $17.46 | $1.2M | 17,836 |
| 2022-04-01 | Morrison Briggs President, Head of R&D | Option exercise · Stock Options (Right to buy) | −70,545 | 0 | ||
| 2022-03-01 | Madigan Catherine Chief Medical Officer | Grant or award · Stock Options (Right to buy) | +180,000 | $16.06 | $2.9M | 180,000 |
| 2022-02-02 | Metzger Michael A Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +325,000 | $15.79 | $5.1M | 325,000 |
| 2022-02-02 | Morrison Briggs President, Head of R&D | Grant or award · Stock Options (Right to buy) | +160,000 | $15.79 | $2.5M | 160,000 |
| 2022-02-02 | Ordentlich Peter Chief Scientific Officer | Grant or award · Stock Options (Right to buy) | +80,000 | $15.79 | $1.3M | 80,000 |
| 2022-02-02 | Meyers Michael L. SVP, Chief Medical Officer | Grant or award · Stock Options (Right to buy) | +17,350 | $15.79 | $274K | 17,350 |
| 2022-02-01 | Ordentlich Peter Chief Scientific Officer | Sale | −1,412 | $16.65 | $24K | 0 |
| 2022-01-31 | Ordentlich Peter Chief Scientific Officer | Other acquisition | +1,412 | $12.39 | $17K | 1,412 |
| 2022-01-31 | Meyers Michael L. SVP, Chief Medical Officer | Other acquisition | +1,714 | $12.39 | $21K | 23,280 |
Page 15 of 15 · 290 trades